跳至主要内容
临床试验/ITMCTR2200006843
ITMCTR2200006843尚未招募1 期

Clinical Study on Shugan Tiaoshen Acupuncture Intervention for Patients with Generalized Anxiety Disorder Under Epidemic Situation

Shenzhen Bao'an Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • ( 1 ) Patients who met the above diagnostic criteria of generalized anxiety disorder in Chinese and Western medicine and were diagnosed in the context of the new coronavirus epidemic ;
  • ( 2 ) Hamilton Anxiety Scale ( HAMA ) 14 determination = 14 points and < 29 points ;
  • ( 3 ) Age = 18 years, = 65 years ;
  • ( 4 ) those who have not received medication, physical or psychological treatment in the past three weeks, or those in stable condition ;
  • signed informed consent and volunteered to participate in this study.

排除标准

  • ( 1 ) Patients who do not meet the inclusion criteria ;
  • ( 2 ) patients with a history of brain trauma, epilepsy, or accompanied by liver and kidney dysfunction, metal implants or severe physical organic diseases such as cardiovascular, cerebrovascular, liver and kidney ;
  • ( 3 ) Patients with other anxiety symptoms of schizophrenia, bipolar disorder or other mental disorders, physical illness ;
  • ( 4 ) Patients with previous or current suicide plan or behavior, psychotic symptoms or anxiety caused by alcohol, drug abuse or withdrawal after addiction ;
  • ( 5 ) Patients with poor compliance or fear of acupuncture ;
  • ( 6 ) Pregnant and lactating women.

研究者

发起方
Shenzhen Bao'an Traditional Chinese Medicine Hospital

相似试验